Research

Researchers identified a sample of Medicare beneficiaries with an incident diagnosis of atrial fibrillation.

Researchers find that the largest Medicare Advantage plans pay large markups for dialysis, especially to large dialysis organizations.

There is little evidence that older adults prescribed benzodiazepines—drugs commonly used to treat anxiety, insomnia and seizures—are at increased risk of developing dementia.

State-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.

Researchers examined correlations between participants’ race/ethnicity and other socio-demographic characteristics and affinity with these eating identities.

Researchers evaluate prescription drug claims from Medicare Part D beneficiaries to evaluate the current spending distribution.

Researchers analyzed historical trends in medically integrated dispensing among oncology practices.

Researchers estimate the individual-level social benefits of diabetes remission through bariatric surgery and compare the population-level effects of expanding eligibility alone versus improving utilization for currently eligible individuals.

Researchers use the Future Elderly Model to estimate potential benefits of disease-modifying therapies for Alzheimer disease.

Advances in machine learning (ML) and artificial intelligence offer tremendous potential benefits to patients. Predictive analytics using ML are already widely used in healthcare operations and care delivery, but how can ML be used for health economics and outcomes research (HEOR)? To answer this question, ISPOR established an emerging good practices task force for the application of ML in HEOR.